Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction by Lluciá Valldeperas, Aida et al.
Tissue Engineering and Regenerative Medicine
Electromechanical Conditioning of Adult Progenitor
Cells Improves Recovery of Cardiac Function After
Myocardial Infarction
AIDA LLUCIA`-VALLDEPERAS,a,* CAROLINA SOLER-BOTIJA,a,* CAROLINA GA´LVEZ-MONTO´N,a
SANTIAGO ROURA,a,b CRISTINA PRAT-VIDAL,a ISAAC PEREA-GIL,a BENJAMIN SANCHEZ,c,d
RAMON BRAGOS,c GORDANA VUNJAK-NOVAKOVIC,e,f ANTONI BAYES-GENISa,g,h
Key Words. Biophysical stimulation x Cardiac adipose tissue-derived progenitor cells x
Tissue engineering x Cardiac regeneration x Electromechanical conditioning x
Myocardial infarction
ABSTRACT
Cardiac cells are subjected to mechanical and electrical forces, which regulate gene expression and
cellular function. Therefore, in vitro electromechanical stimuli could benefit further integration of
therapeutic cells into the myocardium. Our goals were (a) to study the viability of a tissue-
engineered construct with cardiac adipose tissue-derived progenitor cells (cardiac ATDPCs) and (b)
to examine the effect of electromechanically stimulated cardiac ATDPCs within a myocardial infarc-
tion (MI) model in mice for the first time. Cardiac ATDPCs were electromechanically stimulated at
2-millisecond pulses of 50 mV/cm at 1 Hz and 10% stretching during 7 days. The cells were harvested,
labeled, embedded in a fibrin hydrogel, and implanted over the infarcted area of the murine heart. A
total of 39 animals were randomly distributed and sacrificed at 21 days: groups of grafts without cells
and with stimulated or nonstimulated cells. Echocardiography and gene and protein analyses were
also carried out. Physiologically stimulated ATDPCs showed increased expression of cardiac transcrip-
tion factors, structural genes, and calcium handling genes. At 21 days after implantation, cardiac func-
tion (measured as left ventricle ejection fraction between presacrifice and post-MI) increased up to
12% in stimulated grafts relative to nontreated animals. Vascularization and integration with the host
blood supply of grafts with stimulated cells resulted in increased vessel density in the infarct border
region. Trained cells within the implanted fibrin patch expressed main cardiac markers and migrated
into the underlying ischemic myocardium. To conclude, synchronous electromechanical cell condi-
tioning before delivery may be a preferred alternative when considering strategies for heart repair
after myocardial infarction. STEM CELLS TRANSLATIONALMEDICINE 2016;5:1–12
SIGNIFICANCE
Cardiac cells are constantly subjected tomechanical and electrical signals. Hence, in vitro electrome-
chanical stimuli could benefit further cell integration and retention into themyocardium. Electrome-
chanical conditioning of adipose-derived progenitor cells promoted a cardiogenic-like phenotype in
vitro,whichdrove cardiac function recovery and increased vessel densitywhen tested in amyocardial
infarctionmodel in vivo. This is the first study to report thebenefits of electromechanically stimulated
cells in an in vivo scenario. This physiological strategy seems promising to recover cardiac function
after myocardial infarction and is ready for preclinical testing and clinical use.
INTRODUCTION
Cardiovascular diseases remain the most com-
moncauseofmortalityworldwide [1].Myocardial
infarction (MI) leads to irreversible sequelae of
events leading to impaired heart function and,
in some cases, to shorter lifespan [2]. Heart trans-
plantation, a valid therapeutic option for patients
with a terminally failing heart, is hampered by
the lownumber of donor organs [3], whereasme-
chanical ventricular assist devices aremostly used
as a bridge to transplant [4]. With the first clinical
trial, cardiac tissue engineering is now emerging
as a new therapeutic modality [5]. Most cardiac
tissue-engineering approaches combine cells
with biomaterials in a three-dimensional (3D)
context [6].
In the developing and adult heart, cardiac
cells are constantly subjected to cyclic loading in-
ducedbyelectrical signals.Mechanical stretch im-
proves contractility [7], facilitates secretionof growth
factors and calcium handling in cardiomyocytes,
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and modifies extracellular matrix synthesis in cardiac fibroblasts
[8]. In general, mechanical stretch seems to improve heart mus-
cle survival, cell alignment, elongation, hypertrophy, and dif-
ferentiation [9]. The associated electrical signals are crucial for
synchronized contraction of cardiac muscle, enhancing impulse
propagation, ultrastructural organization, cell elongation, and
alignmentand the formationof functional gap junctions [9–13].Ac-
cordingly, synchronous application of electrical and mechanical
stimuli has the potential to benefit engineered cardiac construct
properties. Nevertheless, electromechanical conditioning remains
a relatively unexploited technology, and the efforts are more fo-
cused on engineered heart tissues suitable for disease modeling
than on cell therapy purposes [14, 15]. We recently optimized an
electromechanical stimulationprotocol for engineering heartmus-
cle constructs from neonatal rat heart cells, achieving a positive
force-frequency relationship [15].
The optimal cell lineage for cardiac regeneration is yet to be
defined. Our group has characterized a population of human ad-
ipose tissue-derived progenitor cells of cardiac origin (cardiac
ATDPCs). Cardiac ATDPCs reside in the epicardial fat and display
cardiac and endothelial differentiation potential, as well as ben-
eficial histopathological and functional effects, both when in-
jected as a cell solution into the infarct border zone [16] and
when introduced within a fibrin patch [17]. Here we investigated
electromechanical conditioning of cardiac ATDPCs before encap-
sulation ina fibrin scaffold thatwas implantedonto ischemicmyo-
cardium of infarcted mice to boost cardiac function.
MATERIALS AND METHODS
Human ATDPC Isolation and Culture
Human ATDPCs were isolated from cardiac (cardiac ATDPCs) and
subcutaneous (subcutaneous ATDPCs) adipose tissues obtained
from patients undergoing cardiac surgery, under a protocol ap-
proved by the Germans Trias i Pujol University Hospital Ethics
Committee. Informed consent was obtained from all patients,
and the study protocol conformed to the principles of the Decla-
ration of Helsinki. Tissues were obtained from a total of 11 pa-
tients (cardiac adipose tissue) and 6 patients (subcutaneous
adipose tissue). The cells isolated from each tissue source were
pooled and used for experiments. Subcutaneous ATDPCs were
used as control cells for cardiac ATDPC in vitro experimentation.
Adipose tissue biopsy samples were harvested and processed
as described previously [16]. Briefly, samples were rinsed with
phosphate-buffered saline (PBS) and cut into small pieces, and vis-
ible blood vessels were removed; next, cells were isolated by col-
lagenase II (Thermo Fisher Scientific Life Sciences, Waltham, MA,
http://www.thermofisher.com) digestion. Adhered cells were
grown in a-minimum essential medium (Sigma-Aldrich, St. Louis,
MO, http://www.sigmaaldrich.com) supplemented with 10%
fetal bovine serum (Thermo Fisher Scientific Life Sciences),
1 mM L-glutamine (Thermo Fisher Scientific Life Sciences), and
1%penicillin/streptomycin (ThermoFisher Scientific Life Sciences),
and cultured under standard conditions (37°C and 5% CO2).
Electromechanical Stimulation Device
The custom-made electromechanical stimulation unit is an im-
provement of the electrical stimulation setup already described
[10]. This one consisted of a combination of a monophasic
programmable electrical device, a printed circuit board that
facilitated the robust connection of the electrodes, and a bio-
compatible polydimethylsiloxane (PDMS) (Sylgard 184, Dow
Corning Corp., Washington, DC, https://www.dowcorning.
com) silicone construct designed to provide structural support
to cells, electrodes and magnets (Fig. 1A, 1B). The disposable
stimulation silicone accommodates a cell culture pool in a flex-
ible area (1 cm3 1 cm3 2 mm) and holds two electrodes built
with platinum wire wrapped around a polytetrafluoroethylene
core, placed at two opposing sides of the flexible area creating
an electric field to induce electrical stimulation. To provide a
mechanical stimulation simultaneously and synchronously with
the electrical one, two neodymium magnets (Supermagnete,
Gottmadingen, Germany, https://www.supermagnete.de/eng)
were embedded in the PDMS constructs (Fig. 1A, 1B). The use
of magnets enables the performance of noninvasive mechan-
ical stimulation. Two additional magnets are placed outside
the culture plates. One of them is static and fixes one end of
the silicone construct, and the second one pulls the other
end, following a programmable pattern from a computer-controlled
linearmotor (LM2070-040-11+MCLM3006S, Faulhaber, Scho¨naich,
Germany, https://www.faulhaber.com). The device has six parallel
channels to provide stimulation to up to six culture plates
and permits the combination of both electrical andmechanical
stimulation, either independently or synchronously. Pulse am-
plitudes, durations and periods, delay between electrical and
mechanical pulses, and mechanical pulse shape are program-
mable through a LabView (National Instruments, Austin, TX,
http://www.ni.com) custom application (Fig. 1C).
Cell Culture With Electromechanical Conditioning
Concisely, 33 104 cells were seeded on each PDMS construct
1 day before the beginning of the stimulation. The conditioning
lasted 7 days, and unstimulated cells were used as a control for
electromechanical conditioning, while subcutaneous ATDPCs
were used as a control for cardiac ATDPCs. The electrome-
chanical conditioning protocol consisted of alternating cur-
rent 2-millisecond monophasic square-wave pulses of 50 mV/cm
at 1 Hz and 10% stretching for 7 days. This was conducted six
times (with at least three replicates each) for the in vitro exper-
imentation (gene and protein analyses), and 7 days was the
endpoint. Immunostainings were performed on the cells at-
tached to the PDMS construct and fixed with 10% formalin at
day 7. Gene analyses were carried out after the trypsinization
of the cells attached to the PDMS construct for both control
and stimulated groups (n = 6).
For the animal studies, cardiac ATDPCs were harvested from
stimulatedor unstimulated PDMSconstructs after 7 days, and the
fibrin patch was immediately produced and kept under standard
culture conditions for less than 24 hours before it was implanted.
Briefly, 13 105 cells were mixed with 8 ml of fibrinogen solution
(70–110mg/mL), followed by the addition of 8ml of thrombin so-
lution (500 UI/mL) for jellification (Tissucol duo; Baxter, Utrecht,
The Netherlands, http://www.baxter.nl). The area of the fibrin
patch was ∼7 mm2 and ∼1 mm in height. Fibrin patches were
freshly produced in nine sequential procedures (one procedure
every surgery day) for the whole in vivo experimentation (n = 39
animals), and 21 days was the endpoint. Echocardiographic mea-
surements were acquired at baseline (2 days before the surgery),
post-MI (2 days after the surgery), and at presacrifice (21 days after
the surgery) for all animals.
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Animal Studies
The animal study protocol was approved by the Institutional An-
imal Care and Use Committee (CSIC-ICCC, Cardiovascular Re-
search Center) and complied with guidelines concerning the
use of animals in research and teaching, as defined by the Guide
for the Care and Use of Laboratory Animals (NIH Publication No.
80-23). All procedures were performed in accordance with both
the national and European legislation (Spanish Royal Decree RD
53/2013 and EU Directive 2010/63/EU) for the protection of an-
imals used for research experimentation.
MI Model and Fibrin-Cell Patch Delivery
Briefly, mice were anesthetized with a mixture of O2/isoflurane (2%)
(Baxter), intubated, and mechanically ventilated (90 breaths per
minute, 0.1-ml tidal volume) by using a SAR830/AP small animal ven-
tilator (CWE, Inc., Ardmore, PA, http://www.cwe-inc.com). An ante-
rior thoracotomy was performed, and the proximal left anterior
descending (LAD) coronary arterywas occluded by using a 7-0 silk su-
ture. Sham animals were operated on in the same manner with no
occlusion of the LAD coronary artery before implantation of the
fibrin-cell patches. To generate the adhesive construct, Tissucol solu-
tion(8ml)with13105cellsorculturemediumwasmixedwith8ml of
thrombin solution for jellification (Tissucol duo; Baxter). Fibrin
patches with or without cardiac ATDPCs were implanted by using
Glubran surgical glue (Cardiolink, Barcelona, Spain, http://www.
cardiolink.es), which fulfills the required safety and compatibility
standards for use in experimental animals and humans, to seal
the edge of the patch to the myocardium. The animals were sacri-
ficed 21 days after the operation. By using cardioplegic solution,
Figure 1. Electromechanical stimulator. (A): SolidWorks design of the printed circuit board used to performelectromechanical conditioning on
six 3.5-cmcultureplates (left), anddetail of a PDMSsilicone substrate (right). (B):Electromechanical stimulator (left) and side viewmagnification
(right). (C): Diagram showing the stimulation regimen applied to the cultured cells: electrical (blue) and mechanical (red) stimulations. Pulse
durations and periods, delay between electrical and mechanical pulses, and mechanical pulse shape were programmable through a LabView
custom application. Abbreviations: EIS, electrical impedance spectroscopy; PDMS, polydimethylsiloxane; ref., reference.
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hearts were arrested in diastole and then excised, fixed in 10% for-
malin solution (Sigma-Aldrich), cryopreserved in 30% sucrose in
PBS, embedded in optimum cutting temperature (Sakura Finetek
Europe B.V., AV Alphen aan Den Rijn, The Netherlands, http://
www.sakura.eu), and snap-frozen in liquid nitrogen-cooled isopen-
tane for histological analysis.
Experimental Groups
The studywas performed on 39 female SCIDmice (11–15weeks old
and weighing 20–25 g; Charles River Laboratories, Frederick, MD,
http://www.criver.com) using cardiac ATDPCs. Cells were labeled
before fibrinpatch inclusionbyusing thePKH26RedFluorescentCell
Linker Kit for General Cell Membrane Labeling (Sigma-Aldrich)
following manufacturer’s protocol. Mice were distributed ran-
domly into the following groups: MI alone (MI) (n = 8), MI with
cell-free fibrin implants (MI+Fibrin) (n = 6),MIwith implantation
of fibrin loadedwith na¨ıve control cardiac ATDPCs (MI+Con) (n =
8), andMI with implantation of fibrin loadedwith electromechan-
ically conditioned (EMC) cardiac ATDPCs (MI+EMC) (n = 5). Sham
groups that lacked MI and underwent implantation of control
fibrin-cell patches (Sham+Con) (n = 7) and EMC fibrin-cell patches
(Sham+EMC) (n=5) servedas controlgroups toobtain theeffectsof
cardiacATDPCs onhealthymyocardium. The globalmortality in the




Total RNA was isolated from cardiac and subcutaneous ATDPCs by
using theAllPrepRNA/ProteinKit (Qiagen,Hilden,Germany,http://
www.qiagen.com). cDNAwas synthesizedbyusing randomhexam-
ers (Qiagen) and the iScript One-Step reverse-transcriptase poly-
merase chain reaction (RT-PCR) kit (Bio-Rad, Hercules, CA, http://
www.bio-rad.com)according tothemanufacturer’sprotocol. cDNA
waspreamplifiedwiththeTaqManPreAmpMasterMixKit (Applied
Biosystems, Foster City, CA, http://www.appliedbiosystems.com)
and then diluted 1:5 with RNase-free water.
Real-time PCR amplifications were performed with 2.5 ml of
cDNA in a final volume of 10 ml, containing 5 ml of TaqMan 23
Universal PCR Master Mix, 2 ml of RNase-free water, and 0.5 ml
of 6-carboxyfluorescein amidite (6-FAM)-labeled primer/probe
(Applied Biosystems), including glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) (Hs99999905_m1), T-box transcription
factor (Tbx5) (Hs00361155_m1), myocyte-specific enhancer fac-
tor 2A (MEF2A) (Hs01050409_m1), GATA-binding protein 4 (GATA-
4) (Hs00171403_m1), a-actinin (ACTN1 gene) (Hs00241650_m1),
cardiac troponin I (cTnI, TNNI3 gene) (Hs00165957_m1), con-
nexin43 (Cx43, GJA1 gene) (Hs00748445_s1), sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA2, ATP2A2 gene) (Hs00544877_m1),
and b-myosin heavy chain 7 (b-MyHC,MYH7 gene) (Hs00165276_m1).
The following cardiac markers were evaluated: transcription fac-
tors (Tbx5, MEF2A, and GATA-4), structural markers (a-actinin,
cTnI, and b-MyHC), and calcium handling-related markers
(Cx43 and SERCA2).
Data were collected and analyzed in duplicate on the Light
Cycler 480 Real-Time PCR System (Roche, Indianapolis, IN,
http://www.roche.com). The Livak method was used to quantify
the absolute (22DDCT) and relative (22DCT) expression of each
gene between electromechanically conditioned and control sam-
ples, using GAPDH as an endogenous reference.
Immunofluorescence and Morphometric Examination
Cellsattached to thePDMSconstructwere fixedwith10%formalin,
permeabilized, blocked in 10% normal horse serum for 1 hour, and
incubated for 1 hour at room temperaturewith primary antibodies
raisedagainstCx43 (6.4mg/ml;Sigma-Aldrich), sarcomerica-actinin
(11.5 mg/ml ascites fluid; Sigma-Aldrich), GATA-4 (4 mg/m.; R&D
Systems Inc., Minneapolis, MN, https://www.rndsystems.com),
MEF2 (4 mg/ml; Santa Cruz Biotechnology, Santa Cruz, CA, http://
www.scbt.com), and SERCA2 (4mg/ml; Santa Cruz Biotechnology).
Secondary antibodies were conjugated with Cy2 and Cy3
(7.5 mg/ml; Jackson ImmunoResearch, West Grove, PA, https://
www.jacksonimmuno.com), and actin fibers (actinF) were stained
with Phalloidin Alexa 568 (0.161 mM; Thermo Fisher Scientific Life
Sciences). Nuclei were counterstained with 49,6-diamidino-2-
phenylindole (DAPI) (0.1 mg/ml; Sigma-Aldrich). Images were
acquiredwith the Axio Observer Z1 invertedmicroscope (Zeiss,
Stuttgart, Germany, http://www.zeiss.com).
Hearts were cross-sectioned from apex to base (10-mm-thick
sections spaced every 300mm). Eight serial cryosections per animal
were stained with Masson’s trichrome (collagen, green; myocar-
dium, red; nuclei, black or brown; cytoplasm, pink) for morphome-
try. All sections were blindly examined and photographed using a
SMZ 800 stereoscope (Nikon, Tokyo, Japan, http://www.nikon.
com). Infarct size volume, expressed as apercentageof the total left
ventricle (LV)wall volume, was calculated by addition of partial scar
volumes of each section. Scar thickness was calculated as themean
of at least threemeasurementsmade in three different sections for
each animal. Additionally, Gallego’s modified trichromic (collagen,
blue;myocardium,yellow-pink;elastic fibers,purple;nuclei, fuchsia)
and Movat’s pentachromic (nuclei, black; collagen, yellow; ground
substance, blue;muscle, purple; elastic fibers, brownish gray) stain-
ings were carried out on heart cross-sections from all groups.
Further immunoanalyses were performed on cryosections by
using specific monoclonal antibodies against Cx43 (Sigma-Aldrich),
sarcomeric a-actinin (Sigma-Aldrich), GATA-4 (R&D Systems),
MEF2 (Santa Cruz Biotechnology), SERCA2 (Santa Cruz Biotechnol-
ogy), biotinylatedGSLI B4 isolectin (10mg/ml; Vector Laboratories,
Burlingame, CA, http://vectorlabs.com), cTnI (10 mg/ml; Abcam,
Cambridge, MA, http://www.abcam.com), phospho-histone H3
(PH3) (1 mg/ml; Cell Signaling Technology, Beverly, MA, http://
www.cellsignal.com), CD31 (4mg/ml; Abcam), smoothmuscle actin
(SMA) (1:50 ascites fluid; Sigma-Aldrich), and vimentin (10 mg/ml;
Abcam). Secondary antibodies were conjugated with Cy2 and Cy3
(Jackson ImmunoResearch). Streptavidinwas conjugatedwithAlexa
488 (Thermo Fisher Scientific Life Sciences). Nuclei were counter-
stained with DAPI (Sigma-Aldrich). Images were captured under a
laser confocal microscope (Axio-Observer Z1; Zeiss). Quantitative
histological measurements were made by using ImageJ analysis
software (NIH, Bethesda, MD, https://imagej.nih.gov).
Cell Viability Analysis
To determine cell viability in the fibrin patches, the Live/Dead
viability/cytotoxicity kit (Thermo Fisher Scientific Life Sciences)
was used according to the manufacturer’s instructions. Fibrin
patches loadedwith13105 cellswere cultured for 3weeksunder
standard culture conditions and thenwashed in PBS before stain-
ing. The stained patch constructs were analyzed and quantified by
using the confocal microscope (Axio-Observer Z1; Zeiss), andMax-
imum Projection Intensity plus Tiles-stitching image postprocess-
ing were applied (Zen Blue software; Zeiss).
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Vessel Density
The vessel area was assessed in sections stained with biotinylated
GSLI B4 isolectin (10mg/ml; Vector Laboratories) for border and re-
mote regions from the scar in all animals, in which at least six fields
per regionwerecountedbyan investigatorblindedto the treatment
groups. For shamanimals, because the scar is absent, the border re-
gion corresponds to the patchmargin, and the remote region to the
opposite and furthest region from the patch. Lectin staining was
measured with the ImageJ analysis software (NIH) and normalized
by its fieldarea.Next, thebordervaluewascorrectedbythe remote
one, and this was represented as the vessel density percentage.
Analysis of Cardiac Function
Cardiac function was assessed by echocardiography using an 18- to
38-MHz linear-array transducer with a digital ultrasound system
(Vevo2100 Imaging System,VisualSonics, Toronto,Ontario, Canada,
http://www.visualsonics.com). Measurements were made at base-
line, 2days afterMI, and21days after surgery (presacrifice) for all 39
animals. The investigators were blinded to the treatment groups.
Standard parasternal short-axis views were obtained in B and M
modes. Functional parametersweremeasured, including left ventri-
cle fractional shortening, LV ejection fraction (LVEF), LV anteriorwall
thickness, LV posterior wall thickness, LV end-diastolic dimension,
and LV end-systolic dimension.
Statistical Analysis
Relative fold changes of cardiac and subcutaneous ATDPC gene
expressions were compared by using Student’s t test, and the
statistical difference was determined for the samples from six
separate experiments. Vessel density and morphometry were
Figure 2. Gene and protein analyses after electromechanical conditioning of ATDPCs. 33 104 cells were seeded on each polydimethylsiloxane con-
struct 1 day before the beginning of the stimulation, and the cells attached were used for gene and protein analyses. (A): Real-time polymerase chain
reaction of main cardiac genes in cardiac and subcutaneous ATDPCs. Relative expression of cardiomyogenic markers in EMC versus nonconditioned
controls is shown for cardiac and subcutaneous ATDPCs. Values were normalized to glyceraldehyde-3-phosphate dehydrogenase expression and are
shownasmean6SEMforsix independentexperiments.#,p, .1 (trend);p,p, .05(significance)versusthesubcutaneousATDPCgroup. (B–M):Protein
expression in cardiac and subcutaneousATDPCsona vertical patterned surface, perpendicular to theelectric field (E) and stretching (force; F), as shown
onthesuperiordrawing.Phalloidinstaining(actinF; red)andCx43expression(green),SERCA2(red),MEF2(green),sarcomerica-actinin(red),andGATA-
4 (green) expression in control (B, D, F,H, J, L) andEMC (C, E,G, I, K,M) cardiac (left) and subcutaneous (right) ATDPCs.Nucleiwere counterstainedwith
DAPI (blue; B–E, L, M). Scale bars = 50 mm. Abbreviations: b-MyHC, b-myosin heavy chain 7; ATDPCs, adipose tissue-derived progenitor cells; cTnI,
cardiac Troponin I; Cx43, connexin43; DAPI, 49,6-diamidino-2-phenylindole; EMC, electromechanically conditioned; GATA-4, GATA-binding protein
4; MEF2A, myocyte-specific enhancer factor 2A; SERCA2, sarco/endoplasmic reticulum Ca2+-ATPase; Tbx5, T-box transcription factor.
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assessed by using one-way analysis of variance (ANOVA) and
Tukey post hoc analysis for multiple comparisons. Greenhouse-
Geisser analysis was used for LVEF repeated measures (baseline
and post-MI) to confirm homogeneity of surgical procedure.
Paired-samples t test was also used to compare differences be-
tween baseline and presacrifice echocardiographic parameters
in each experimental group. The LVEF differentials (DLVEF)
between presacrifice and baseline were evaluated by using
one-wayANOVAandTukeypost hocanalysis formultiple compar-
isons. All the results are presented as themean6 SEM; p, p, .05
was considered statistically significant. Statistical analyses were




Electrical andmechanical conditioningswere first applied individ-
ually to optimize each protocol. Electrical conditioning was based
on a previous publication in which alternating current 2-millisec-
ond monophasic square-wave pulses of 50 mV/cm at 1 Hz were
found optimal [10]. Synchronous mechanical conditioning was
performed with an ad hoc custom magnet-driven system (Mate-
rials andMethods) operated at a frequency of 1 Hz and a strain of
10% for 7 days (Fig. 1; supplemental online Movie 1). Briefly, 33
104 cells were seeded on the silicone surface and subjected to
stimulation, with changes of culturemedium twice aweek. Unsti-
mulated cells were used as a control for electromechanical con-
ditioning. Subcutaneous ATDPCs were used as a control for
cardiac ATDPCs.
Physiological Conditioning Promotes Expression of
Cardiac Genes and Proteins
Electromechanical conditioning modulated gene expression in
both cell types, with cardiac ATDPCs showing a stronger upregula-
tion of cardiac genes (Fig. 2A). In cardiac ATDPCs, Tbx5 (p = .081),
GATA-4 (p = .050), and Cx43 (p = .025) increased approximately
twofold comparedwith subcutaneousATDPCs, in response toelec-
tromechanical conditioning. Additionally, significant and higher in-
creases were observed on key structural and calcium-related
genes, such as b-MyHC (fivefold, p = .000) and SERCA2 (2.8-fold,
p = .076) in cardiac ATDPCs EMC samples compared with controls.
The protein expression of main cardiac markers in noncondi-
tioned controls and EMC ATDPCs is shown in Figure 2B–2M. Cx43
was mostly distributed in the cytoplasm and at the plasma mem-
brane to allow cell connections through gap junctions (Fig. 2B–2E).
MEF2 was expressed in the nuclei, and SERCA2 and a-actinin
were observed in the cytoplasm without mature sarcomere or-
ganization or synchronous beating (Fig. 2F–2M). GATA-4 protein
expression was detected only in the nuclei of control and EMC
cardiac ATDPCs (Fig. 2J, 2K).
Viability and Migration of Physiologically Trained
Cardiac ATDPCs in 3D Fibrin Gel
Cardiac ATDPCswere labeledwith PKH26and cultured in vitro in a
3D fibrin gel to assess cell tracking and viability before in vivo im-
plantation. After 21 days of in vitro culture, the fibrin patchmain-
tained its initial morphology and size (Fig. 3A), and the cells
retained the PKH26 labeling (Fig. 3B). Importantly, ∼84% of cells
(green fluorescence) remained viable (Fig. 3C).
Figure 3. Macroscopic evaluation of the three-dimensional engineered construct with cardiac adipose tissue-derived progenitor cells (cardiac
ATDPCs) cultured for 21 days before in vivo grafting. (A): Brightfield image composition of the cellular fibrin patch under standard culture con-
ditions. (B, B9): PKH26 cell labeling (red) of cardiac ATDPCs in the fibrin patch (B) and magnification of the core region (B9). (C): Representative
image showing cell viability (green cells, alive; red cells, dead) in a fibrin patch loadedwith cardiac ATDPCs, as performed by the live/dead assay.
(C9):Magnificationof a construct border zonewith anabundanceof viable cells (green). (D):Representative photographof anexcisedheart from
a postinfarction animal (visible ligation) 21 days after the cellular fibrin construct implantation (asterisk). (E, E9): Representative image of
Masson’s trichromic staining of heart cross-section fromamyocardial infarction plus electromechanically conditioned-treated animal (E) and
its magnification (E9). Scale bars = 1 mm (A–E) and 20 mm (B9, C9).
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The engineered fibrin construct was implanted over the in-
farcted area in the murine model of acute MI (Fig. 3D) and over
healthy myocardium (sham animals). After 21 days, the physio-
logically engineered construct (MI+EMC) was nicely attached to
the myocardium and almost indiscernible through macroscopic
observation (Fig. 3D, 3E). Construct’s adaptation to the murine
myocardium surface is shown in different heart cross-sections
of MI+EMC animals (Fig. 3E; supplemental online Fig. 1).
Cardiac ATDPCs migration to underlying ischemic myocardium
was observed only occasionally in both control and EMC fibrin
constructs (Fig. 4A, 4I). De novo expression of cTnI was identified
in some of the implanted cells (Fig. 4A). Cardiac ATDPCs within
the fibrin patch also contained Cx43, GATA-4, SERCA2, MEF2, and
a-actinin (Fig. 4A–4E), suggesting that the cardiomyogenic lineage
gained in vitro persisted in vivo. Additional proof of cell phenotype
is the absence of PH3, associated with proliferation, from cardiac
ATDPCs (data not shown). Moreover, DAPI staining showed ade-
quatemorphologyofcellnuclei, evidencing thatcells remainedalive.
Remarkably, murine cell migration between the host tissue
and the engineered construct was observed in all treated groups
Figure 4. Migration and differentiation of electromechanically conditioned cardiac adipose tissue-derived progenitor cells (cardiac ATDPCs) in
amousemodel of myocardial infarction. Immunofluorescence analysis of heart cross-sections at 21 days for cTnI (green) and Cx43 (gray) (A–C);
GATA-4 (gray) and cTnI (green) (C); SERCA2 (gray) and MEF2 (green) (D); sarcomeric a-actinin (gray) and CD31 (green) (E); vimentin (gray) and
cTnI (green) (F–H); and SMA (gray) and cTnI (green) (I–K). Cardiac ATDPCswere labeledwith PKH26 (red fluorescence), and nuclei were counter-
stained with 49,6-diamidino-2-phenylindole (blue). Circles indicate the migration of cardiac ATDPCs into murine tissue. Arrowheads show rep-
resentative expressions of the protein of interest in each panel. Scale bars = 20mm.Abbreviations: cTnI, cardiac Troponin I; Cx43, connexin43; F,
fibrin; GATA-4, GATA-binding protein 4; M, myocardium; MEF2A, myocyte-specific enhancer factor 2A; S, scar; SERCA2, sarco/endoplasmic
reticulum Ca2+-ATPase; SMA, smooth muscle actin.
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Figure 5. Vascular analysis. (A–D): GSLI B4 isolectin staining (green) showing vessel-like structures within the fibrin construct at 21 days after
infarction, as well as in the myocardium-fibrin interphase (A, B). An isolectin-positive vessel (green) connects the murine myocardium stained
with cTnI (gray) and the fibrin patch (C). Cardiac ATDPCs (red) colocalization with vascular structures GSLI B4 isolectin positive (green) (C, D).
Nuclei were counterstained with DAPI (blue). Arrowheads indicate vessels andmicrovessels (A–C) and colocalization (C, D). Scale bars = 20mm.
(E–G, E9, F9):MI+EMC heart cross-sections stainedwith light greenMasson’s trichromic (E), Gallego’smodified trichromic (F), andMovat’s pen-
tachromic stainings (G), and theirmagnifications (E9, F9). Functional vesselswitherythrocytes areobserved in the fibrin construct andconnecting
themyocardiumwith the fibrin gel (E9, F9). Arrowheads indicate the presence of erythrocytes inside the vessels. Scale bars = 20mm. (H): Histo-
gram showing the vessel density expressed as the percentage ratio between border and remote areas occupied by isolectin-positive cells in
control (MI andMI+Fibrin) and cardiac ATDPC-treated (MI+Con andMI+EMC) groups. Sham-operated animals are also present and considered
standard references. (I): Scar thickness (millimeters) for all infarcted groups. Values aremean6 SEM.p,p, .05;ppp,p, .0001.All animalswere
(Figure legend continues on next page.)
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andwasmost obvious in animals in which a cell-free fibrin hydro-
gel was implanted (supplemental online Fig. 2). Analysis of the
colonized spindle-shaped cell population observed in the fibrin
patch was positive for vimentin and smooth muscle actin, sug-
gesting the presence of fibroblasts and myofibroblasts (Fig.
4F–4K; supplemental online Fig. 2).
Neovascularization of Engineered Fibrin Constructs and
Underlying Myocardium
Fluorescence microscopy demonstrated neovascularization of
the fibrin patches in all groups (Fig. 5A–5G; supplemental
online Fig. 1). Remarkably, colocalization of the GSLI B4 isolectin
endothelial marker and PKH26within the fibrin construct and the
underlying scar suggests that EMC cardiac ATDPCs were inte-
grated into vascular structures (Fig. 5C, 5D). Moreover, we also
observed vessel connections between the murine myocardium
and the engineered fibrin construct (Fig. 5C, 5G). Refined histo-
logical analysis confirmed the presence of erythrocytes inside
the vessels within the fibrin construct (Fig. 5E, 5E9, 5F, 5F9), dem-
onstrating the functionality and interconnectivity of these con-
struct neovessels with host tissue circulation (Fig. 5G). SMA
was also abundant around scar vessels and engineered fibrin con-
struct neovessels (Fig. 4I–4K; supplemental online Fig. 2).
Vessel density was measured in the border zone of the in-
farcted tissue. Isolectin staining showed∼14%greater vessel den-
sity in the subjacent myocardium that received fibrin patches
loaded with both control and EMC cardiac ATDPCs than from
MI controls (p = .007 and p = .030 forMI+Con andMI+EMC versus
MI, respectively) (Fig. 5H). A trend of increase in infarct border
zone neovascularization was also observed in the MI+Fibrin
group, suggesting that fibrin alonemay have angiogenic potential
in the ischemic myocardium, an effect that was significantly en-
hanced when the construct was embedded with cardiac ATDPCs.
Scar volumewas measured for each animal by usingMasson’s
trichrome staining. Amoderate decrease in scar sizewas observed
forMI+EMC animals (20.85%) comparedwithMI animals (26.25%)
(supplemental online Fig. 3), not reaching statistical significance.
Scar thickness was also measured for each animal by using
Masson’s trichrome staining (Fig. 5I). A relevant increase in scar
thickness was observed for MI+Con (0.20 6 0.04 mm) and MI
+EMC (0.23 6 0.08 mm) animals compared with MI (0.14 6
0.02 mm) and MI+Fibrin (0.15 6 0.01 mm) groups (p = .001 for
MI+Con and p, .0001 for MI+EMC versus MI group).
Implantation of a Physiologically Conditioned
Engineered 3D Patch Prevents Ventricular Remodeling
and Drives Cardiac Function Recovery After MI
Echocardiographic analyses were conducted to determine
whether EMC cardiac ATDPCs exerted a beneficial effect on the
restoration of cardiac function afterMI (Fig. 6). Statistical analysis
confirmed a similar reduction in cardiac function assessed by left
ventricle ejection fraction in all infarct groups (p = .14). Significant
adverse remodeling assessed by increased ventricular diameters
(left ventricle enddiastolic diameter and left ventricle end systolic
diameter) and depressed function (LVEF and left ventricle short-
ening fraction) was observed inMI andMI+Fibrin groups; no such
ventricular remodeling was present in the MI+Con and MI+EMC
groups (Table 1; supplemental online Table 1). The difference in
left ventricle ejection fraction (DLVEFsacrifice-baseline) between the
baseline and presacrifice values was calculated (supplemental
online Table 2). Remarkably, 80% of MI+EMC animals presented
a DLVEFsacrifice-baseline $ 25% (p, p = .03), which is considered
(Figure legend continued from previous page.)
included in the analysis (n = 39). Abbreviations: Con, control; cTnI, cardiac Troponin I; DAPI, 49,6-diamidino-2-phenylindole; EMC, electrome-
chanically conditioned; MI, myocardial infarction alone; MI+Con, myocardial infarction with implantation of fibrin loaded with na¨ıve control
cardiac adipose tissue-derived progenitor cells; MI+EMC, myocardial infarction with implantation of fibrin loaded with electromechanically
conditioned adipose tissue-derived progenitor cells; MI+Fibrin, myocardial infarction with cell-free fibrin implants; Sham+Con, sham groups
that lacked myocardial infarction and underwent implantation of control fibrin-cell patches; Sham+EMC, sham groups that lacked myocardial
infarction and underwent implantation of electromechanically conditioned fibrin-cell patches.
Figure 6. Functional analysis. Left ventricle ejection fraction (LVEF) assessed by echocardiography at baseline, 2 days post-MI, and at 21 days
(presacrifice), in the parasternal short-axis view, relative to their LVEF value at baseline. Mean values6 SEM. All animals were included in the
analysis (n = 39). Abbreviations: DLVEF, left ventricle ejection fraction differentials between presacrifice and post-MI; Con, control; EMC, elec-
tromechanically conditioned;MI,myocardial infarction alone;MI+Con,myocardial infarctionwith implantation of fibrin loadedwith na¨ıve con-
trol cardiac adipose tissue-derived progenitor cells;MI+EMC,myocardial infarction with implantation of fibrin loadedwith electromechanically
conditioned adipose tissue-derived progenitor cells; MI+Fibrin, myocardial infarction with cell-free fibrin implants.
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clinically relevant. In contrast, only 0% (MI), 33% (MI+Fibrin), and
50% (MI+Con) of the animals not treated with EMC cells pre-
sented clinically relevantDLVEFsacrifice-baseline ($25%). The LVEF
trend among the studied groups is shown in Figure 6. Assessment
of DLVEFsacrifice-MI (presacrifice 2 post-MI) in MI+EMC animals
showed mean values 5%, 11%, and 12% higher than those ob-
served for MI+Con, MI+Fibrin, and MI, respectively (Fig. 6).
DISCUSSION
Cardiac cells are normally subjected to electrical and mechanical
forces that regulate gene expression and cellular function. The
synchronously applied electromechanical conditioning used here
was intended to mimic the native cardiac milieu. Both electrical
[10] and mechanical protocols were optimized to comply with
physiological conditions.
Cardiac and subcutaneous ATDPCs have been described as
attractive cell sources for cardiac cell therapy. Indeed, cardiac
ATDPCs constitutively express main cardiac genes (GATA-4,
a-actinin, cTnI, Cx43, and SERCA2), have immunomodulatory
properties, andexhibit both cardiomyogenic and endothelial line-
age potential when implanted over the infarctedmurinemyocar-
dium [16–18]. In a clinical setting, cardiac ATDPCs could be easily
obtained through lateral thoracotomy from patients undergoing
cardiac surgery. Cells can be expanded and electromechanically
conditioned in vitro. Interestingly, the gene expression acquired
with the conditioning remained after the stimulation, which
would permit cell freezing to preserve themuntil the conditioned
cells are required and delivered during the surgery. Cell delivery
could have several approaches, such as the fibrin patch, which is
easy to generate once the cells are thawed and is currently being
evaluated in a clinical trial [5].
Previously, we explored the effect of electrostimulation alone
on cardiac ATDPCs. Relative to EMC cardiac ATDPCs, electrostimu-
lated cardiac ATDPCs exhibited similar expression patterns for the
modulation of cardiac transcription factors, but notably lower lev-
els for structural genes [10]. In fact, EMC cardiac ATDPCs exhibit el-
evatedexpressionof structural and calcium-handling relatedgenes
(a-actinin,b-MyHC, and SERCA2), alongwithdecreasedexpression
of MEF2A compared with electrostimulation alone. This compari-
son suggests that electrical stimulation on cardiac ATDPCs induces
early cardiac markers [10], whereas electromechanical stimulation
affectsbothearlyand latecardiacmarkers,alsodetectedat thepro-
tein level. Moreover, lack of a proliferation marker, such as PH3,
and the cTnI expression detected in vivo support a cardiac lineage
commitmentwhenEMCcellsareembedded ina fibrinpatch,which
is then implanted in the murine myocardium.
Although individual electrical or mechanical cellular condi-
tioning has been tested previously in vivo [7, 19–21], this work
is the first to combine electrical and mechanical conditioning
simultaneously for adipose tissue progenitor cells and use them
for therapeutic purposes. Indeed, simultaneous electrical andme-
chanical stimulation have previously only been analyzed in vitro
[13, 15, 22], and this report is the first to study its beneficial effects
at the in vivo physiological level. Previous in vitro studies reported
improved functional properties and increased SERCA2 and car-
diac Troponin T expression after delayed electromechanical stim-
ulation [13]; efficient cardiac differentiation ofmesenchymal stem
cells when 5-azacytidine and electromechanical stimulation were
applied [22]; and functional maturation of engineered heart mus-
cle with a positive force-frequency relationship after electrome-
chanical stimulation at 4 Hz [15].
Furthermore, the engineered fibrin construct increased
vessel density in the myocardium adjacent to the scar (border
region), and this effect was significantly enhanced by the
presence of cardiac ATDPCs [17]. Implanted EMC cardiac ATDPCs
promoted the sprouting of blood vessels in the underlying myo-
cardium and within the construct. Bayes-Genis et al. postulated
that cardiac ATDPCs might have a paracrine effect, promoting lo-
cal vascularization by secreting proangiogenic factors under hyp-
oxic conditions [16], and this vasculogenic potential persisted
after the electromechanical conditioning. Hoke et al. previously
pointed out three putative mechanisms of action for adipose
stem cells: myocyte regeneration, neovascularization and para-
crine activity. These mechanisms may act cooperatively [23] to
prevent ventricular remodeling after MI, an achievement that
is crucial to clinical success.
Table 1. Cardiac function parameters
Group LVEDD (mm) LVESD (mm) LVFS (%) LVEF (%)
Sham+Con
Baseline 3.46 0.2 2.36 0.2 33 6 4 63 6 5
Presacrifice 3.56 0.2 2.46 0.3 31 6 7 59 6 11
p value .74 .6 .7 .55
Sham+EMC
Baseline 3.36 0.2 2.26 0.2 33 6 5 62 6 7
Presacrifice 3.56 0.1 2.36 0.2 33 6 5 62 6 7
p value .19 .48 .96 .87
MI
Baseline 3.56 0.1 2.36 0.1 34 6 3 63 6 4
Presacrifice 3.96 0.3 2.96 0.4 24 6 4 48 6 7
p value .03a .01a .01a .01a
MI+Fibrin
Baseline 3.56 0.3 2.46 0.2 30 6 1 58 6 2
Presacrifice 3.86 0.3 2.96 0.3 24 6 4 47 6 7
p value .03a .02a 0.06 .05a
MI+Con
Baseline 3.56 0.2 2.56 0.1 29 6 2 57 6 3
Presacrifice 3.96 0.5 2.86 0.6 28 6 6 55 6 10
p value .11 .2 .76 .62
MI+EMC
Baseline 3.76 0.1 2.66 0.1 28 6 3 55 6 5
Presacrifice 3.86 0.5 2.76 0.3 27 6 4 55 6 5
p value .68 .76 .78 .97
Values are shown as mean 6 SEM.
ap , .05.
Abbreviations: EMC, electromechanically conditioned; LVEDD, left
ventricle end-diastolic dimension; LVESD, left ventricle end-systolic
dimension; LVFS, left ventricle fractional shortening; LVEF, left ventricle
ejection fraction; MI, myocardial infarction alone; MI+Con, myocardial
infarction with implantation of fibrin loaded with na¨ıve control cardiac
adipose tissue-derived progenitor cells; MI+EMC, myocardial infarction
with implantationof fibrin loadedwithelectromechanically conditioned
adipose tissue-derived progenitor cells; MI+Fibrin, myocardial
infarction with cell-free fibrin implants; Sham+Con, sham groups that
lacked myocardial infarction and underwent implantation of control
fibrin-cell patches; Sham+EMC, sham groups that lacked myocardial
infarction and underwent implantation of electromechanically
conditioned fibrin-cell patches.
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Even though there was no improvement on cardiac ATDPC
vasculogenic potential after electromechanical stimulation, their
capacity to improve mice cardiac function, compared with non-
treated animals, was shown. Mice treated with cell-enriched
engineered fibrin constructs (MI+Con and MI+EMC) exhibited a
frank increase in contractile parameters compared with un-
treated (MI) or cell-free fibrin constructs (MI+Fibrin) upon sacri-
fice. However, ventricular remodeling and cardiac function were
bestwith EMCcardiac ATDPC fibrin constructs. Themechanismof
action is not fully understood, but as Hoke et al. postulated [23],
the cooperation between new functional cardiac-like cells on the
infarction site, increased vascularization on the border region of
the scar, and paracrine signaling of implanted cells may help in
tissue restoration, and it contributes to the functional improve-
ment. New functional cells, some of them committed to the car-
diovascular lineagemigrating to the ischemic and healthymurine
myocardium, will also benefit myocardial repair. In the same line,
neovascularization on scar margins is translated to more oxygen
and nutrient supply, which helps in tissue regeneration. Finally,
cardiac ATDPC secretion of proangiogenic and cardioprotective
factors will enhance cardiac regeneration. In the same line, cell
delivery of cells embedded in a fibrin patchwas previously report-
ed [17] as a beneficial approach, with slight contribution to car-
diac recovery and without harmful effects for the animal.
Only 1 3 105 EMC cardiac ATDPCs induced an 8% improve-
ment of cardiac function. Functional results reported previously
[17, 24–29] used 2- to 15-fold more cells than we used and
achieved smaller or comparable improvements. A plausible justi-
fication for this enhanced cardiac function in cell-treated animals
is that trained cardiac ATDPCs prevented LV dilation. Indeed, the
global functional benefits of the 3D construct may not be re-
stricted to local infarct size reduction, but may also have distant
far-reaching effects on the infarct border zone, as well as on
noninfarcted tissue [26, 30]. Together, the significant benefits
achieved by this very low cell dose (13 105 EMC cardiac ATDPCs)
may have a translation to the clinic. It is calculated that humans
would need 1010 to 1011 cells for sufficient engraftment [31], be-
ing a prohibitive number for routine cell therapy. Then, the use of
EMCcells has thepotential todrastically reduce the cell dose, sup-
porting bench to bedside transition.
Host murine cells migrated to the fibrin patch regardless of
the presence of embedded cardiac ATDPCs. The migratory cells
were stained with antibodies raised against vimentin and SMA
to demonstrate the migration of fibroblasts and myofibroblasts
to the fibrin constructs. Prior description of the enhancement
of fibroblast migration by fibrinogen, especially during healing
processes [32], supports this observation.
The ad hoc design of the electromechanical stimulator, which
uses 3.5-cm cell culture plates, limits the number of cells used for
implantation, and it is one of our study limitations. A scaled-up
device would allow implantation of a greater number of cells
needed formyocardial regeneration for largemammalian hearts,
although our physiological conditioning data support beneficial
effects with significantly fewer cells. The final time point here
was 21 days, comparable with other publications [33]. However,
some recommend longer follow-up times, arguing that midterm
data should be interpreted cautiously, yet some differences were
no longer significant afterward [34]. Finally, in this study, we did
not aim to obtain beating cells, such as neonatal cardiomyocytes
or embryonic stem cell-derived cardiomyocytes. Indeed, we
worked with adult progenitor cells, whose cardiovascular
potential has already been described [16, 35–37]. In vivo implanta-
tion of EMC cardiac ATDPCs contributes to cell transdifferentiation
and electromechanical coupling to themurinemyocardium,which
mayguide thebeating frequencyandavoidarrhythmias.Adult pro-
genitor cells areeasilyobtained,and their clinical translationhasno
ethical concerns. Collectively, our study presents a more commit-
ted phenotype of adult progenitor cells toward the cardiovascular
lineage, with enhanced potential, and improved cardiac function
when implanted on the murine model of MI. Therefore, EMC cells
could be suitable for clinical application, yetnoethical concernsap-
ply, and benefits on preclinical models have been shown.
CONCLUSION
We report a new protocol for synchronous electromechanical
conditioning of adipose tissue-derived progenitor cells from car-
diac adipose tissue, and the use of conditioned cells in an engi-
neered 3D fibrin patch for treating infarcted myocardium in a
murine model. In fact, this study is the first to examine the effect
of electromechanically conditioned cells in an in vivo scenario.
This work provides evidence that electromechanically condi-
tioned ATDPCs maintain their cardiomyogenic potential within
the in vivo environment, migrate to the murine myocardium
and scar, improve cardiac function after MI, and increase vessel
density. Synchronous electromechanical conditioning of ATDPCs
before delivery onto infarcted heart emerges as a promising ther-
apeutic strategy to recover cardiac function after MI.
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